Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.
about
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant GliomaSurvival in glioblastoma: a review on the impact of treatment modalities.A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Immunological effects of chemotherapy and radiotherapy against brain tumors.A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.Recurrent glioma clinical trial, CheckMate-143: the game is not over yet.Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.Immunotherapies for malignant glioma.Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo.[Corticosteroids compromise survival in glioblastoma patients after radio- and chemotherapy].Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.
P2860
Q26770399-B9FD8624-A879-4857-9FFC-08BCC64C42BFQ30251810-57BFA11E-A518-404E-BE45-932BFEC3A740Q31130812-AC386CF0-725E-491C-9453-DC70332B45E7Q38619307-22934760-55C2-43F0-9FBC-482EC1D8756EQ38919780-63DADF9E-DDF9-4A4D-9B36-B38FB5FC7E33Q38947116-ED69F5C9-0DD5-4EF1-9C6A-3A46B391B6D1Q39366720-3973A98F-6D58-41B4-9EC0-4A3964F9CBE1Q43099390-A575F1BE-D70B-441E-B5EF-7D21B0E24A81Q43099393-B4B5A6DE-1005-4049-9770-F45492241D33Q46586294-490BE4A8-78B0-4216-8F18-465BE1F82F28Q47140355-EBC9C8EA-946E-4815-82DF-0E5BE43576BBQ47577963-2027873A-AD81-45A0-AD34-C75660CE9C7DQ47915209-0841EAAA-FCCA-4E2A-B184-00D6216FE2EBQ50002230-E82CA933-A30A-4EE2-AE04-A32E8478D878Q50238409-F951BFE5-1B19-4422-B38C-50EAAEEEA3F5Q52590678-17866313-9845-4DFB-83E2-0837301241C0Q52780147-9739230E-5DE0-4344-8E71-814EEB799AF2
P2860
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@ast
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@en
type
label
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@ast
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@en
prefLabel
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@ast
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@en
P2093
P2860
P356
P1476
Dexamethasone exerts profound ...... cy for recurrent glioblastoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2015.238
P407
P577
2015-06-30T00:00:00Z